• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS 6000 C (501) MODULE; CLINICAL CHEMISTRY ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS 6000 C (501) MODULE; CLINICAL CHEMISTRY ANALYZER Back to Search Results
Catalog Number 05860636001
Device Problem Low Test Results (2458)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/19/2024
Event Type  Injury  
Event Description
The initial reporter received questionable ise indirect na for gen.2 results from multiple patient samples tested on the cobas 6000 c501 (ul) v.The reporter stated the questionable results from (b)(6) 2024 had to be corrected.Please refer to the attachment (b)(4) for the table containing the examples of questionable na results.
 
Manufacturer Narrative
The electrode lot number and the expiration date were requested but not provided.The field service engineer (fse) inspected the analyzer and determined the event was caused by a leak in the connection of solenoid valve (sv) 28 from the reference bottle.He then inspected the error trace and did not find indicators of any issues.He inspected and cleaned the ion-selective electrode (ise) reference bottle filter and performed an initial precision test with poor results.He cleaned the valve, reformed the connection, and reinstalled the valve.He verified the module's performance with ise primes, repeat precision tests, and recalibrations with acceptable results.After service, no further issues were reported by the customer.The investigation determined the service actions resolved the issue.
 
Manufacturer Narrative
On 24-apr-2024, the customer provided additional questionable ise indirect na and k for gen.2 results and medical information for the patients whose samples were tested on the reported cobas 6000 c (501) module.It was alleged that patients were admitted to the hospital based on the low sodium results.There was no report of any other alleged harm or injury.Medwatch fields b1 and b2 were updated out of an abundance of caution.Please refer to the attachment pt-0067940 in the medwatch for the highlighted additional questionable results and additional medical information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS 6000 C (501) MODULE
Type of Device
CLINICAL CHEMISTRY ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
HITACHI HIGH TECH CORP.
882 ichige hitachinaka
ibaraki 312-8 504
JA   312-8504
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key19031260
MDR Text Key339223755
Report Number1823260-2024-01016
Device Sequence Number1
Product Code JJE
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K060373
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05860636001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2024
Initial Date FDA Received04/03/2024
Supplement Dates Manufacturer Received04/24/2024
Supplement Dates FDA Received05/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
0319:C02615 - HYDROCHLOROTHIAZIDE; 0319:C02615 - LOSARTAN
Patient Outcome(s) Required Intervention; Other; Hospitalization;
-
-